Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep265 | Calcium and Vitamin D metabolism | ECE2015

Severe refractory hypocalcaemia associated with osteoblastic metastatic breast carcinoma

Lal Vikram , Ashwell Simon , Humphreys Alison , Nag Sath

Introduction: Hypercalcaemia is well associated with metastatic malignancy. Hypocalcaemia is an uncommon complication of osteoblastic metastases and occurs most commonly with breast and prostate carcinoma.Case: A 46-year-old woman with metastatic breast carcinoma and osteoblastic skeletal metastases treated with denosumab presented with severe symptomatic hypocalcaemia. Serum calcium was persistently low with a nadir value of 1.45 mmol/l (2.2–2.6) a...

ea0034p383 | Thyroid | SFEBES2014

Incidence of Sunitinib induced thyroid dysfunction in renal cell carcinoma: a pilot retrospective audit

Zhyzhneuskaya Sviatlana , Erete Leanna , Czechowska Justyna , Anderson Wendy , Humphreys Alison , Nag Sath

Introduction: TKI are an emerging group of anti-growth factor agents used in the treatment of solid cancers. Treatment is associated with thyroid dysfunction. Sunitinib is licensed for the treatment of metastatic RCC. Our objective was to determine the incidence of Sunitinib induced thyroid dysfunction and its management in patients with renal RCC.Methods: Retrospective case note analysis of patients started on Sunitinib for metastatic RCC between Januar...